PBMs have manipulated the market to enrich themselves - hiking up drug costs, cheating employers, and driving small pharmacies out of business. My new bipartisan bill will untangle these conflicts of interest by reining in these middlemen.
The bill aims to prevent parent companies of pharmacy benefit managers from owning pharmacy businesses, protecting independent pharmacies and ensuring fairer access to prescription drugs for consumers.
Senators and representatives are taking a bipartisan approach to combat the monopolistic practices of PBMs, with a focus on addressing conflicts of interest and ensuring competition in the healthcare market.
The Federal Trade Commission has raised concerns about the significant influence PBMs have on prescription drug availability and pricing, necessitating bipartisan legislative action to reform the system.
#patients-before-monopolies-act #pharmacy-benefit-managers #healthcare-legislation #bipartisan-efforts #ftc-oversight
Collection
[
|
...
]